Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QK1R | ISIN: KYG4987A1094 | Ticker-Symbol: 77V
Düsseldorf
27.06.25 | 19:30
0,440 Euro
-7,95 % -0,038
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
JACOBIO PHARMACEUTICALS GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
JACOBIO PHARMACEUTICALS GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,4360,49013:02
0,4400,48627.06.

Aktuelle News zur JACOBIO PHARMACEUTICALS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.06.JACOBIO-B (01167): SEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION2
10.06.JACOBIO-B (01167): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 20251
22.05.JACOBIO-B (01167): INSIDE INFORMATION - JACOBIO'S KRAS G12C INHIBITOR GLECIRASIB APPROVED FOR MARKET LAUNCH1
14.05.JACOBIO-B (01167): FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING2
14.05.JACOBIO-B (01167): NOTICE OF 2025 ANNUAL GENERAL MEETING-
14.05.JACOBIO-B (01167): PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED AMENDMENTS ...-
JACOBIO PHARMACEUTICALS GROUP Aktie jetzt für 0€ handeln
09.05.JACOBIO-B (01167): PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ...1
09.05.JACOBIO-B (01167): VOLUNTARY ANNOUNCEMENT SHP2 INHIBITOR SITNEPROTAFIB COMBINATION THERAPY DATA PUBLISHED IN ACADEMIC JOURNAL1
30.04.JACOBIO-B (01167): VOLUNTARY ANNOUNCEMENT CHANGES IN THE INTERESTS OF THE PARTIES ACTING IN CONCERT-
25.04.JACOBIO-B (01167): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS3
25.04.JACOBIO-B (01167): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS-
24.04.JACOBIO-B (01167): 2024 ANNUAL REPORT3
16.04.JACOBIO-B (01167): NEXT DAY DISCLOSURE RETURN1
19.03.Jacobio Pharma Announces 2024 Annual Results255BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense...
► Artikel lesen
19.03.JACOBIO-B (01167): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
19.03.JACOBIO-B (01167): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024; CHANGE IN USE OF PROCEEDS; AND CHANGE IN THE COMPOSITION OF THE NOMINATION ...1
07.03.JACOBIO-B (01167): DATE OF BOARD MEETING-
06.01.JACOBIO-B (01167): VOLUNTARY ANNOUNCEMENT THE REGISTRATIONAL CLINICAL DATA OF KRAS INHIBITOR GLECIRASIB WAS PUBLISHED IN THE MEDICAL JOURNAL NATURE MEDICINE1
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1